OXON Epidemiology at ESMO Congress 2026: From Real-World Data to Reliable Evidence

23–27 October 2026 | IFEMA Madrid, Spain | Booth #8085, Hall 8

OXON Epidemiology will be exhibiting at ESMO Congress 2026, one of the leading international events in oncology, taking place in Madrid from 23 to 27 October.

As advances in cancer treatment continue to reshape clinical practice, the need for reliable evidence beyond controlled clinical trials remains essential. Real-World Evidence (RWE) provides valuable insights into treatment patterns, safety, effectiveness and patient outcomes across diverse populations and routine care settings.

Supporting Oncology Research with Real-World Evidence

At OXON, we work with pharmaceutical and biotechnology companies to design and deliver scientifically rigorous research that addresses the evolving evidence needs of oncology.

Our expertise encompasses primary, secondary and hybrid observational studies, patient registries, post-authorisation research and late-phase studies, supported by integrated epidemiology, biostatistics, data management and clinical operations capabilities.

From understanding how treatments perform in everyday clinical practice to generating evidence for regulatory and healthcare decision-making, we help turn complex real-world data into meaningful, reliable evidence.

Let’s Meet at ESMO 2026

Our team will be available at Booth #8085, Hall 8, to discuss your oncology research objectives, upcoming studies and opportunities for collaboration.

Whether you are developing an evidence generation strategy or looking for an experienced CRO partner, we would be delighted to connect.

We look forward to welcoming you to our stand in Madrid.